Starting from April, the capping of ceiling prices of scheduled drugs listed under the National List of Essential Medicines (NLEM) has resulted in a 6.73% reduction of average costs for 651 essential medicines, according to the National Pharmaceutical Pricing Authority (NPPA). The government has been able to fix the ceiling prices of 651 medicines so far out of the total 870 scheduled drugs listed under NLEM.
